Breast Development and Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breast Development and Cancer

Published:2023-03-13 Issue:6 Volume:15 Page:1731
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Berliere Martine¹²,Duhoux Francois P.¹³,François Aline¹⁴,Galant Christine¹⁴

Affiliation:

1. Breast Clinic, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium

2. Department of Gynecology, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium

3. Department of Medical Oncology, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium

4. Department of Pathology, King Albert II, Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium

Abstract

The human breast, as mentioned by Gudjonsson and co-authors [...]

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/15/6/1731/pdf

Reference10 articles.

1. Ingthorsson, S., Traustadottir, G.A., and Gudjonsson, T. (2022). Cellular Plasticity and Heterotypic Interactions during Breast Morphogenesis and Cancer Initiation. Cancers, 14.

2. Berliere, M., Coche, M., Lacroix, C., Riggi, J., Coyette, M., Coulie, J., Galant, C., Fellah, L., Leconte, I., and Maiter, D. (2022). Effects of Hormones on Breast Development and Breast Cancer Risk in Transgender Women. Cancers, 15.

3. PIN1 in Breast Development and Cancer: A Clinical Perspective;Rustighi;Cell Death Differ.,2017

4. Rana, P.S., Wang, W., Alkrekshi, A., Markovic, V., Khiyami, A., Chan, R., Perzynski, A., Joseph, N., and Sossey-Alaoui, K. (2021). YB1 Is a Major Contributor to Health Disparities in Triple Negative Breast Cancer. Cancers, 13.

5. Shen, Y., Singh, J., Sah, B., Chen, Z., Ha, W., Henzler, C., Su, T., Xie, L., Deng, Y., and Li, G. (2022). The Histone Demethylase HR Suppresses Breast Cancer Development through Enhanced CELF2 Tumor Suppressor Activity. Cancers, 14.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3